Impact of a primary care pharmacist consultations on pregnant women ’s medication use: the SafeStart intervention study linked to a national prescription database

ConclusionThis study did not detect an impact of a pharmacist consultation on pregnant women ’s use of medications. In the future, pharmacist consultations should focus on other outcome factors, such as risk perception, knowledge level, and the use of other health care services.Trial registration The SafeStart study is registered with ClinicalTrials.gov (identifier: NCT04182750, registration date: December 2, 2019).
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research